Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 499 entries
View as:

Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06368141 Org: User:
Start: 05/01/24 End: 04/30/26 Due: 04/30/27

Arsenic Trioxide in Refractory Solid Tumors With Rescuable p53 Mutation

Phase: N/A Priority: Normal
NCT ID: NCT04869475 Org: User:
Start: 04/20/21 End: 04/30/24 Due: 04/30/25

The Efficacy and Safety of Chidamide, Anti-PD-1 Antibody in Combination With Pegaspargase Versus DDGP in the Treatment of Newly Diagnosed, Stage III to IV Extranodal Natural Killer/T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06255795 Org: User:
Start: 02/15/24 End: 12/31/28 Due: 12/31/29

PD-1 Inhibitor Tislelizumab Maintenance Therapy in R/R DLBCL Patients After ASCT

Phase: N/A Priority: Normal
NCT ID: NCT04799314 Org: User:
Start: 04/01/21 End: 04/01/24 Due: 04/01/25

Quantitative Flow Ratio on Radial Artery Graft Outcome After Coronary Artery Bypass Grafting

Phase: N/A Priority: Normal
NCT ID: NCT05556590 Org: User:
Start: 10/09/22 End: 04/30/23 Due: 04/30/24

Multi-omics Studies of Host-microbiome Interaction in Chronic Obstructive Pulmonary Disease and Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT05738044 Org: User:
Start: 02/20/23 End: 06/30/24 Due: 06/30/25

Anesthesia and Lymphocytes Apoptosis

Phase: N/A Priority: Normal
NCT ID: NCT01461551 Org: User:
Start: 10/31/11 End: 10/31/14 Due: 10/31/15

Neoadjuvant Aromatase Inhibitor(AI) With Ovarian Suppression Versus Chemotherapy in Premenopausal Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02532400 Org: User:
Start: 03/31/16 End: 03/31/19 Due: 03/31/20

Effects of Early Stage Mini-invasive Abdominal Drainage on Complications and Prognosis of SAP

Phase: N/A Priority: Normal
NCT ID: NCT02002793 Org: User:
Start: 08/31/13 End: 08/31/17 Due: 08/31/18

Remote Magnetic Versus Manual Navigation-guided Ablation for Non-outflow Tract Premature Ventricular Contractions: a Prospective, Randomized, Controlled Trial

Phase: N/A Priority: Normal
NCT ID: NCT04519112 Org: User:
Start: 10/01/20 End: 09/30/23 Due: 09/30/24

Single-incision Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03633539 Org: User:
Start: 08/31/20 End: 12/31/25 Due: 12/31/26

Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04435197 Org: User:
Start: 08/11/20 End: 06/30/24 Due: 06/30/25

The Efficacy and Mechanism of DBS in VIC and NAcc for Refractory OCD

Phase: N/A Priority: Normal
NCT ID: NCT04228744 Org: User:
Start: 01/10/20 End: 12/31/22 Due: 12/31/23

Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial (Cohort 1)

Phase: N/A Priority: Normal
NCT ID: NCT04508686 Org: User:
Start: 08/01/20 End: 08/01/24 Due: 08/01/25

Investigating the Clinical Features and Prognosis of Bronchiectasis Adult Patients

Phase: N/A Priority: Normal
NCT ID: NCT04987827 Org: User:
Start: 11/01/21 End: 06/30/23 Due: 06/30/24

Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04973293 Org: User:
Start: 10/01/22 End: 12/31/25 Due: 12/31/26

CAR T-cell Therapy in Combination With Glofitamab for Relapsed/Refractory Large B-Cell Lymphoma With High-Risk Prognostic Factors

Phase: N/A Priority: Normal
NCT ID: NCT06567366 Org: User:
Start: 09/30/24 End: 09/30/27 Due: 09/30/28

Super Hypofractionated Irradiation for Whole Breast Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04926766 Org: User:
Start: 01/23/21 End: 07/10/28 Due: 07/10/29

Deep Brain Stimulation of Nucleus Accumbens for Methamphetamine Addiction

Phase: N/A Priority: Normal
NCT ID: NCT03347474 Org: User:
Start: 09/20/17 End: 12/30/20 Due: 12/30/21

Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass Graft

Phase: N/A Priority: Normal
NCT ID: NCT03038009 Org: User:
Start: 10/31/18 End: 12/31/20 Due: 12/31/21

Anlotinib Plus Chemotherapy as First-line Therapy for Gastrointestinal Tumor Patients With Unresectable Liver Metastasis (ALTER-G-001)

Phase: N/A Priority: Normal
NCT ID: NCT05262335 Org: User:
Start: 12/01/21 End: 12/01/24 Due: 12/01/25

A Tolerance Clinical Study on Aerosol Inhalation of Mesenchymal Stem Cells Exosomes In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04313647 Org: User:
Start: 03/12/20 End: 07/31/20 Due: 07/31/21

A Study of Bortezomib Plus GDP in the Treatment of Refractory and Relapsed Non-GCB DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT02542111 Org: User:
Start: 05/31/15 End: 05/31/18 Due: 05/31/19

Simultaneous Integrated Boost for Mediastinal Lymph Node Recurrence After Radical Surgery of Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03990532 Org: User:
Start: 04/30/19 End: 04/30/24 Due: 04/30/25

Adaptive SCS for Treatment of Gait Disturbance in PD

Phase: N/A Priority: Normal
NCT ID: NCT04538131 Org: User:
Start: 07/01/20 End: 12/31/20 Due: 12/31/21